Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Decnupaz Approved for Rare Blood Cancer

Decnupaz Approved for Rare Blood Cancer
ShareXFacebook

(MedPage Today) -- The FDA approved the antibody-drug conjugate pivekimab sunirine (Decnupaz) for the rare hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). The approval stipulates use of the drug in adults. Although...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Sedentary Behavior Linked to Pregnancy Risks, Study Says
MedPage Today

Sedentary Behavior Linked to Pregnancy Risks, Study Says

(MedPage Today) -- New research in JAMA found that pregnant women with sedentary behavior, low step counts, or low levels of light physician activity had higher risks of adverse pregnancy outcomes. In this MedPage Today video, Bethany Barone Gibbs...

Read more →
Advertisement